SOLA PHARMACEUTICALS
Live / Registered — Registered (as of 06 Jul 2021)
What this means for you
Registered since 06 Jul 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 06 Jul 2027, and its filing window is open now).
Record
- Serial number
- 90033748
- Registration number
- 6407089
- Mark type
- Word mark
- Filed
- 02 Jul 2020
- Published for opposition
- 17 Nov 2020
- Registered
- 06 Jul 2021
- Next maintenance filing
- §8 declaration of use, due by 06 Jul 2027 (grace period to 06 Jan 2028)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical medications, namely, pharmaceutical preparations for treating pain and skin conditions
Owner
- SOLA Pharmaceuticals, LLC., Baton Rouge, LA, US
- SOLA Pharmaceuticals, LLC., Baton Rouge, LA, US
- SOLA Pharmaceuticals, LLC., Baton Rouge, LA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 90033748 — Solta Medical, Inc. v. SOLA Pharmaceuticals, LLC., filed 15 Dec 2020 (Terminated)
Prosecution history
- 06 Jul 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 27 May 2021 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 15 Dec 2020 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 17 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Nov 2020 — PUBLISHED FOR OPPOSITION
- 28 Oct 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Oct 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Oct 2020 — EXAMINER'S AMENDMENT ENTERED
- 13 Oct 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Oct 2020 — EXAMINERS AMENDMENT E-MAILED
- 13 Oct 2020 — EXAMINERS AMENDMENT -WRITTEN
- 13 Oct 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Oct 2020 — NON-FINAL ACTION E-MAILED
- 13 Oct 2020 — NON-FINAL ACTION WRITTEN